Matthew Reilley, MD, is an associate professor of medicine at the University of Virginia School of Medicine and treats patients with gastrointestinal maligancies. Dr. Reilley’s research is focused on developing new and effective therapies for patients with advanced cancer. He has led dozens of clinical trials and directs the phase 1 clinical trial program at the UVA Comprehensive Cancer Center.

Dr. Reilley earned his medical degree from Brown University. He completed his internal medicine residency at the University of Pennsylvania and a fellowship in hematology & medical oncology at The University of Texas MD Anderson Cancer Center, where he served as chief fellow. He has been recognized for his outstanding patient care and excellence in research. Dr. Reilley is board-certified in medical oncology and internal medicine.